Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 25755772PMCID PMC4348919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR‐146a functions as a tumor suppressor in prostate cancer by targeting Rac1

  2014cited by this paper
• A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer

  2014cited by this paper
• Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.

  2013cited by this paper
• miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells

  2013cited by this paper
• Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection

  2013cited by this paper
• Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.

  2013cited by this paper
• Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers

  2013cited by this paper
• Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.

  2013cited by this paper
• Trends in cancer mortality in China: an update.

  2012cited by this paper
• Cancer treatment and survivorship statistics, 2012

  2012cited by this paper
• Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC).

  2012cited by this paper
• MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF

  2012cited by this paper
• Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab

  2011cited by this paper
• Clinical Significance of miR-146a in Gastric Cancer Cases

  2011cited by this paper
• Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis.

  2011cited by this paper
• A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR

  2011cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2011cited by this paper
• Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.

  2010cited by this paper
• Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

  2010cited by this paper
• Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.

  2010cited by this paper
• miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

  2010cited by this paper
• Causes and consequences of microRNA dysregulation in cancer

  2009cited by this paper
• Circulating microRNAs in breast cancer and healthy subjects

  2009cited by this paper
• Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer

  2009cited by this paper
• Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.

  2009cited by this paper
• Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth

  2008cited by this paper
• The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

  2001cited by this paper

• Research progress of MicroRNA in lung cancer

  2026cites this paper
• Clinical significance of miR-3178 in non-small cell lung cancer patients

  2026cites this paper
• Harnessing miR-145 in NSCLC: mechanistic roles, diagnostic-prognostic utility, and therapeutic potential

  2025cites this paper
• Dual role of mir-146a in non-small cell lung cancer progression: Molecular mechanisms and clinical potential.

  2025cites this paper
• Diagnostic Utility of microRNA146a and microRNA19a in Gallbladder Cancer: A Pilot Study

  2025cites this paper
• Differential Expression of Circulating miR-221-3p, miR-146a-5p, miR-206 and Their Diagnostic Value in Lung Cancer

  2024cites this paper
• Peroxynitrite as biomarker to evaluate the rehabilitation of cisplatin in the resistant cells with miR-125a-5p by using fluorescent assay.

  2024cites this paper
• Circulating Exosomal miRNA Profiles in Non-Small Cell Lung Cancers

  2024cites this paper
• of Potential Noncoding RNAs Related to Spinal Cord Injury Based on Competing Endogenous RNAs

  2024cites this paper
• The critical role and functional mechanism of microRNA-146a in doxorubicin-induced apoptosis in breast cancer cells

  2024cites this paper
• Applications of Exosome Vesicles in Different Cancer Types as Biomarkers.

  2023cites this paper
• Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer

  2023cites this paper
• Modifications of The Human Liver Cancer Cells through microRNA-145-Mediated Targeting of CDCA3

  2023cites this paper
• Automation Radiomics in Predicting Radiation Pneumonitis (RP)

  2023cites this paper
• The Importance of Detecting, Quantifying, and Characterizing Exosomes as a New Diagnostic/Prognostic Approach for Tumor Patients

  2023cites this paper
• Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis

  2023cites this paper
• The lncRNA HOXA11‐AS acts as a tumor promoter in breast cancer through regulation of the miR‐125a‐5p/TMPRSS4 axis

  2022cites this paper
• Dietary regulation of miRNA in precision medicine of lung cancer

  2022cites this paper
• Machine-learning algorithms for asthma, COPD, and lung cancer risk assessment using circulating microbial extracellular vesicle data and their application to assess dietary effects

  2022cites this paper
• Contributions of Circulating microRNAs for Early Detection of Lung Cancer

  2022cites this paper
• Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics

  2022cites this paper
• High‐grade bladder cancer cells secrete extracellular vesicles containing miRNA‐146a‐5p and promotes angiogenesis

  2022cites this paper
• MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential

  2022cites this paper
• Extracellular vesicles in cancer pros and cons: the importance of the evidence-based medicine.

  2022cites this paper
• Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis

  2022cites this paper
• LINC00852 is associated with poor prognosis in non‐small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa‐miR‐145‐5p/KLF4 axis

  2021cites this paper
• The Common miRNAs between Tuberculosis and Non-Small Cell Lung Cancer: A Critical Review

  2021influential citation
• High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer

  2021cites this paper
• Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma

  2021cites this paper
• Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands

  2021influential citation
• Diagnostic and prognostic value of serum miR-145 and vascular endothelial growth factor in non-small cell lung cancer

  2021influential citation
• The effects of all trans retinoic acid, vitamin D3 and their combination on plasma levels of miRNA-125a-5p, miRNA-34a, and miRNA-126 in an experimental model of diabetes

  2021cites this paper
• Dynamics of AQP4 upon exposure to seropositive patient serum before and after Rituximab therapy in Neuromyelitis Optica: A cell-based study.

  2021cites this paper
• Combination of two miRNAs has a stronger effect on stimulating apoptosis, inhibiting cell growth, and increasing erlotinib sensitivity relative to single miRNA in A549 lung cancer cells

  2021cites this paper
• Serum exosomal microRNAs as predictive markers for EGFR mutations in non–small‐cell lung cancer

  2021cites this paper
• Clinico-Pathological Importance of miR-146a in Lung Cancer

  2021cites this paper
• The comparison and evaluation of the miR-16, miR-155 and miR-146a expression pattern in the blood of TB and NSCLC patients: A Research paper

  2021cites this paper
• CMAR_A_232383 485..495

  2020cites this paper
• miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer.

  2020cites this paper
• In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor

  2020cites this paper
• Association of MicroRNA-146a rs2910164 Polymorphism and Lung Cancer in Iranian Population: A Case-Control Study

  2020cites this paper
• Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer

  2020cites this paper
• Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: A systemic review and meta-analysis

  2020cites this paper
• Expression Changes of miR-146a-5p and miR-196a-2 in Non-small Cell Lung Cancer Patients: A Case-control Study

  2020cites this paper
• MiR-125a-5p inhibits cell proliferation, cell cycle progression, and migration while promoting apoptosis in head and neck cancers by targeting ERBB3.

  2020cites this paper
• Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis

  2020cites this paper
• miR-146a-5p Plays an Oncogenic Role in NSCLC via Suppression of TRAF6

  2020cites this paper
• Association between miRNA-146a polymorphism and lung cancer susceptibility: a meta-analysis involving 6,506 cases and 6,576 controls.

  2020cites this paper
• The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.

  2020cites this paper
• Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?

  2020cites this paper
• Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis

  2020cites this paper
• Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer

  2020cites this paper
• Effect and mechanism of miR-146a on malignant biological behaviors of lung adenocarcinoma cell line

  2020cites this paper
• Biomarkers in Pulmonary Research

  2020cites this paper
• Combination of Serum miRNAs with Serum Exosomal miRNAs in Early Diagnosis for Non-Small-Cell Lung Cancer

  2020cites this paper
• Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer: a comparison with plasma total miRNAs

  2019cites this paper
• microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.

  2019cites this paper
• Diagnostic value of serum miR197 and miR145 in non-small cell lung cancer

  2019cites this paper
• miR‐146a‐5p: Expression, regulation, and functions in cancer

  2019cites this paper
• Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations

  2019influential citation
• MicroRNA-30a suppresses papillary thyroid cancer cell proliferation, migration and invasion by directly targeting E2F7

  2019cites this paper
• miR-146a and miR-196a-2 genes polymorphisms and its circulating levels in lung cancer patients.

  2019cites this paper
• Could microRNA be used as a diagnostic tool for lung cancer?

  2019cites this paper
• Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases

  2019cites this paper
• Combining Plasma miRNAs and Computed Tomography Features to Differentiate the Nature of Pulmonary Nodules

  2019cites this paper
• Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma

  2019cites this paper
• Up-Regulation of MiRNA-125a-5p Inhibits Cell Proliferation and Increases EGFR-TKI Induced Apoptosis in Lung Cancer Cells

  2019cites this paper
• Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma

  2019cites this paper
• Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer

  2019cites this paper
• Inhibition of proliferation and invasion of renal cancer cells by miR-125a-5p targeting STAT3 and its possible mechanism

  2019cites this paper
• Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib

  2019cites this paper
• MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A

  2018cites this paper
• Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer.

  2018cites this paper
• The role of plasma miRNAs in the diagnosis of pulmonary nodules.

  2018cites this paper
• Exosomes as Biomarker of Cancer

  2018cites this paper
• A panel of noncoding RNAs in non–small‐cell lung cancer

  2018cites this paper
• The clinical value of miR‐193a‐3p in non‐small cell lung cancer and its potential molecular mechanism explored in silico using RNA‐sequencing and microarray data

  2018cites this paper
• miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2

  2018cites this paper
• A 5-MicroRNA Signature Identified from Serum MicroRNA Profiling Predicts Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer.

  2018cites this paper
• Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

  2018cites this paper
• Epigenomics in tobacco risk assessment: Opportunities for integrated new approaches

  2018cites this paper
• Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer

  2018influential citation
• MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma

  2018cites this paper
• Secretory microRNAs as biomarkers of cancer.

  2017cites this paper
• Small RNAome sequencing delineates the small RNA landscape of pluripotent adult stem cells in the planarian Schmidtea mediterranea

  2017cites this paper
• Circulating cell-free microRNAs as clinical cancer biomarkers.

  2017cites this paper
• Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing

  2017cites this paper
• Applications of Extracellular RNAs in Oncology

  2017cites this paper
• Effect of miR-146a-5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation

  2017cites this paper
• Association of Serum miR-145 with Vascular Endothelial Growth Factor (VEGF) in Patients with Non-Small Cell Lung Cancer

  2017cites this paper
• Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma

  2017cites this paper
• Circulating miRNAs as non-invasive biomarkers for non-small cell lung cancer diagnosis, prognosis and prediction of treatment response.

  2017cites this paper
• Aryl hydrocarbon receptor (AhR)-dependent regulation of pulmonary miRNA by chronic cigarette smoke exposure

  2017cites this paper
• Investigation of microRNA-145 as a serum diagnostic and prognostic biomarker for gastric cancer : a Chinese cohort-based study

  2017cites this paper
• Clinical value of integrated‐signature miRNAs in esophageal cancer

  2017cites this paper
• The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers

  2017cites this paper
• Circulating cell-free microRNAs as clinical cancer biomarkers

  2017cites this paper
• Expression of Chemokine XCL2 and CX3CL1 in Lung Cancer

  2016cites this paper
• Effect and molecular mechanism of mir-146a on proliferation of lung cancer cells by targeting and regulating MIF gene.

  2016cites this paper
• Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC

  2016cites this paper